Medicale Corp. (MCLE)
Medicale Corp. specializes in the distribution of nutritional supplements and offers health-related consulting services within Georgia. Accessible via its online platform, medicalecorp.com, the company's product portfolio includes a diverse range of items such as essential vitamins, minerals, proteins, amino acids, specialized bodybuilding aids, essential fatty acids, natural health products, and probiotics. Additionally, Medicale Corp. maintains an informative blog providing insights into dietary supplements and wellness practices. Established in 2020, the company's operations are headquartered in Tbilisi, Georgia.
Sector: Services-Health Services
Industry: Food Distribution
Medicale Corp
OTC:MCLEConsumer Defensive · Food Distribution
Mkt Cap$2K
Float5.92M
O/S5.92M
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$41K
Total Assets$0
Free Cash Flow-$23K
Debt & Equity
Total Debt$84K
Total Equity-$99K
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in MCLE's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$159
Liabilities$99K
Accounts Receivable$0
Accounts Payable$4K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $2K | $2K | $0 |
| Gross Profit | $0 | $0 | $0 | -$2K | -$2K | $0 |
| Gross Margin | - | - | - | - | - | - |
| Research and Development | $0 | $0 | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $33K | $55K | $38K | $44K | $32K | $23K |
| Other | $33K | $0 | $0 | $0 | $0 | -$21K |
| Total Operating Expenses | $33K | $55K | $38K | $44K | $32K | $2K |
| Operating Income (EBIT) | -$33K | -$55K | -$38K | -$44K | -$32K | -$2K |
| Operating Margin | - | - | - | - | - | - |
| Interest Expense | $8K | $4K | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$8K | -$4K | $0 | $0 | $0 | $0 |
| Income Before Tax (EBT) | -$41K | -$58K | -$38K | -$44K | -$32K | -$2K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$41K | -$58K | -$37K | -$46K | -$32K | -$2K |
| Net Income Margin | - | - | - | - | - | - |
| Supplementary Data | ||||||
| EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 |
| Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 |
| Weighted Average OS | 5.92M | 5.92M | 5.92M | 5.92M | 5.92M | 5.92M |
| EBITDA | -$33K | $0 | $0 | -$42K | -$30K | $21K |
| EBITDA Margin | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $0 | $159 | $159 | $159 | $18K | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $0 | $159 | $159 | $159 | $18K | $0 |
| Accounts Receivable | $0 | $0 | $0 | $0 | $200 | $200 |
| Inventory | $0 | $0 | $0 | $0 | -$200 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | $200 | $0 |
| Total Current Assets | $0 | $159 | $159 | $159 | $19K | $200 |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $12K |
| Intangible Assets | $0 | $0 | $0 | $0 | $10K | $12 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $0 | $0 | $0 | $0 | $10K | $12K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $0 | $159 | $159 | $159 | $28K | $12K |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $0 | $4K | $8K | $25K | $25K | $13K |
| Short-Term Debt | $0 | $0 | $20 | $18 | $12K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | -$18 | -$12 | $0 |
| Other Current Liabilities | $34K | $12K | $32 | $30 | -$12K | $603 |
| Total Current Liabilities | $34K | $16K | $41 | $55 | $37K | $14K |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $0 | $84K | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $73K | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $73K | $84 | $0 | $37 | $25K | $0 |
| Other Liabilities | $0 | $0 | $0 | -$37K | -$25K | $0 |
| Total Liabilities | $106K | $99K | $41K | $55K | $37K | $14K |
| Stockholders' Equity | ||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $592 | $592 | $592 | $592 | $592 | $340 |
| Retained Earnings | -$217K | -$176K | -$118K | -$80K | -$34K | -$2K |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $76K | $76K | $76K | $25K | $25K | $180 |
| Total Equity | -$140K | -$99K | -$41K | -$55K | -$8K | -$1K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | -$34K | $159 | $159 | $0 | $28K | $12K |
| Supplementary Data | ||||||
| Total Debt | $106K | $84K | $20 | $18 | $12K | $0 |
| Net Debt | $106K | $83 | -$138 | $18 | -$18K | $0 |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
| Operating Activities | ||||||
| Net Income | -$41K | -$58K | -$37K | -$46K | -$32K | -$2K |
| Depreciation & Amortization | $0 | $55K | $38K | $2K | $2K | $23K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||
| Accounts Receivable | $0 | $0 | $0 | $200 | $0 | -$200 |
| Inventory | $0 | $0 | $0 | -$200 | $0 | $0 |
| Accounts Payable | $11K | -$5K | $0 | $12K | $0 | $0 |
| Other Working Capital | $18K | -$20K | $11K | $200 | $12K | $1K |
| Total Working Capital Change | $18K | -$25K | $11K | $12K | $12K | $800 |
| Other Non-Cash Items | $18K | -$55K | -$38K | $7K | $12K | -$23K |
| Net Cash from Operating | -$23K | -$84K | -$26K | -$25K | -$18K | -$1K |
| Investing Activities | ||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Activities | ||||||
| Debt Repaid | - | -$84K | - | - | - | - |
| Common Stock Issuance | $0 | $0 | $0 | $0 | $25K | $520 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $23K | $0 | $26K | $6K | $11K | $1K |
| Net Cash from Financing | $23K | $84K | $26K | $6K | $36K | $1K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$159 | $0 | $159 | -$18K | $18K | $0 |
| Supplementary Data | ||||||
| Operating Cash Flow | -$23K | -$84K | -$26K | -$25K | -$18K | -$1K |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$23K | -$84K | -$26K | -$25K | -$18K | -$1K |
| Cash at Beginning | $159 | $159 | $0 | $18K | $0 | $0 |
| Cash at End | $0 | $159 | $159 | $0 | $18K | $0 |